Sanofi (SNY) Enterprise Value (2016 - 2025)
Sanofi's Enterprise Value history spans 10 years, with the latest figure at -$8.9 billion for Q4 2025.
- For Q4 2025, Enterprise Value fell 12.09% year-over-year to -$8.9 billion; the TTM value through Dec 2025 reached -$8.9 billion, down 12.09%, while the annual FY2025 figure was -$8.7 billion, 7.42% down from the prior year.
- Enterprise Value for Q4 2025 was -$8.9 billion at Sanofi, down from -$8.0 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$8.0 billion in Q4 2024 and bottomed at -$13.0 billion in Q4 2022.
- The 4-year median for Enterprise Value is -$10.2 billion (2021), against an average of -$10.4 billion.
- The largest annual shift saw Enterprise Value surged 30.37% in 2021 before it decreased 12.48% in 2022.
- A 4-year view of Enterprise Value shows it stood at -$11.6 billion in 2021, then dropped by 12.48% to -$13.0 billion in 2022, then skyrocketed by 38.81% to -$8.0 billion in 2024, then decreased by 12.09% to -$8.9 billion in 2025.
- Per Business Quant, the three most recent readings for SNY's Enterprise Value are -$8.9 billion (Q4 2025), -$8.0 billion (Q4 2024), and -$13.0 billion (Q4 2022).